Topical anthralin for psoriasis vulgaris: Evaluation of 70 Japanese patients

Journal of Dermatology

Volumn 27, Issue 7, 2000, Pages 482-485

  Yamamoto, T ^a   Matsuuchi, M ^a   Irimajiri, J ^a   Otoyama, K ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Dithranol; Psoriasis vulgaris

Indexed keywords

CYCLOSPORIN; DITHRANOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSORIASIS; PSORIASIS VULGARIS; REMISSION; SKIN IRRITATION; TREATMENT OUTCOME;

EID: 0033862276     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2000.tb02212.x     Document Type: Article

References (19)

1. Treatment of psoriasis
2. Dithranol: A review of the mechanism of action in the treatment of psoriasis vulgaris
3. Dithranol, after 75 years still going strong
4. Comparison Of photochemotherapy with dithranol in the treatment of chronic plaque psoriasis
5. Anthralin therapy for psoriasis: A retrospective study of 39 cases
6. Topical anthralin therapy for refractory nail psoriasis
7. Anti-respiratory and anti-proliferative activity of anthralin in cultured human keratinocytes
8. Multi-functional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils
9. Anthralin (1, 8-dihydroxyanthrone) is a potent inhibitor of leukotrien production and LTB4-omega oxidation by human neutrophils
10. Structure-activity relationship for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones
11. Anti-psoriatic drug anthralin activates transcription factor NF-κB in murine keratinocytes
12. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro
13. Anthralin (dithranol) in vitro inhibits human monocytes to secret IL-6, IL-8 and TNF-α, but not IL-1
14. The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis
15. Factors influencing anthralin erythema
16. The inflammatory response to anthralin
17. Irritation and staining by dithranol (anthralin) and related compounds: 1. Estimation with chamber testing and contact thermography
18. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: A clinical and pathologic study
19. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses